S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

Cullinan Oncology (CGEM) Earnings Date, Estimates & Call Transcripts

$18.06
+0.18 (+1.01%)
(As of 04/18/2024 ET)

Earnings Summary

Upcoming
Earnings Date
May. 9Estimated
Actual EPS
(Mar. 14)
-$0.54 Beat By $0.42
Consensus EPS
(Mar. 14)
-$0.96
Skip Charts & View Estimated and Actual Earnings Data

CGEM Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CGEM Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Cullinan Oncology Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20243($1.00)($0.72)($0.88)
Q2 20244($0.98)($0.67)($0.83)
Q3 20244($1.02)($0.70)($0.86)
Q4 20244($1.06)($0.72)($0.90)
FY 202415($4.06)($2.81)($3.47)
Q1 20251($0.77)($0.77)($0.77)
Q2 20251($0.80)($0.80)($0.80)
Q3 20251($0.82)($0.82)($0.82)
Q4 20251($0.75)($0.75)($0.75)
FY 20254($3.14)($3.14)($3.14)

CGEM Earnings Date and Information

Cullinan Oncology last released its quarterly earnings data on March 14th, 2024. The reported ($0.54) earnings per share for the quarter, topping analysts' consensus estimates of ($0.96) by $0.42. Cullinan Oncology has generated ($3.69) earnings per share over the last year (($3.69) diluted earnings per share). Earnings for Cullinan Oncology are expected to grow in the coming year, from ($3.60) to ($3.47) per share. Cullinan Oncology has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off prior year's report dates.

Cullinan Oncology Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/9/2024
Estimated)
------- 
3/14/2024Q4 2023($0.96)($0.54)+$0.42($0.54)--
11/8/2023Q3 2023($0.91)($0.91)-($0.91)--
8/10/2023Q2 2023($0.99)($0.82)+$0.17($0.82)--
5/11/2023Q1 2023($0.84)($1.42)($0.58)($1.42)--
3/9/2023Q4 2022($0.65)($0.59)+$0.06($0.59)--
11/14/2022Q3 2022($0.97)($0.54)+$0.43($0.54)--
8/10/2022Q2 2022$5.47($2.20)($7.67)($8.17)--
5/16/2022Q1 2022($0.61)($0.27)+$0.34($0.27)--
3/17/2022Q4 2021($0.47)($0.74)($0.27)($0.74)--
11/9/2021Q3($0.4230)($0.40)+$0.0230($0.40)--
8/9/2021Q2 2021($0.42)($0.44)($0.02)($0.36)--

Cullinan Oncology Earnings - Frequently Asked Questions

When is Cullinan Oncology's earnings date?

Cullinan Oncology has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off last year's report dates. Learn more on CGEM's earnings history.

Did Cullinan Oncology beat their earnings estimates last quarter?

In the previous quarter, Cullinan Oncology (NASDAQ:CGEM) reported ($0.54) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.96) by $0.42. Learn more on analysts' earnings estimate vs. CGEM's actual earnings.

How much revenue does Cullinan Oncology generate each year?

Cullinan Oncology (NASDAQ:CGEM) has a recorded annual revenue of $18.94 million.

How much profit does Cullinan Oncology generate each year?

Cullinan Oncology (NASDAQ:CGEM) has a recorded net income of -$153.16 million. CGEM has generated -$3.69 earnings per share over the last four quarters.

What is Cullinan Oncology's EPS forecast for next year?

Cullinan Oncology's earnings are expected to grow from ($3.60) per share to ($3.47) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:CGEM) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners